Código QR (código de barras bidimensional)

The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection

Introduction: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice. Methods: A retrospective cha...

ver descrição completa

Na minha lista:
Principais autores: Trevor A. Stump, PharmD, BCPP, Leigh Anne Nelson, PharmD, BCPP, Yifei Liu, BS Pharm, PhD, Carrie R. Kriz, MS, Courtney A. Iuppa, PharmD, BCPP, Lauren A. Diefenderfer, PharmD, BCPP, Shelby E. Lang, PharmD, BCPP, Ellie S. R. Elliot, PharmD, BCPP, Roger W. Sommi, PharmD, BCPP, FCCP
Formato: Artigo
Idioma:Inglês
Publicado em: American Association of Psychiatric Pharmacists 2021-01-01
coleção:Mental Health Clinician
Assuntos:
paliperidone palmitate
long-acting injectable antipsychotic
oral antipsychotic overlap
benztropine
adverse events
decompensation
Acesso em linha:https://theijpt.org/doi/pdf/10.9740/mhc.2021.01.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados